Dialnet (Universidad de la Rioja) · 1977 · 20 citations · 3 references
MedicinePharmacologyPharmacotherapyDementiaNeuropharmacologyNeuropsychologyCognitive ImpairmentGeriatric NeuropsychiatryGeriatric NeuropsychologyAnticholinergic Burden AssessmentAnticholinergic DrugsCentral Nervous System Anticholinergic EffectsCognitive Impairment AssociationsMedication Effects On CognitionMedication-related Cognitive ImpairmentNeurocognitive Safety Of Medications
Drugs with anticholinergic (antimuscarinic) properties are associated with cognitive impairment in individuals as young as 55 years, and only one such drug per day, regardless of its anticholinergic burden, is associated with both impaired cognition and impaired mobility in old-old adults. Therefore, wherever possible, clinicians should avoid prescribing drugs with anticholinergic properties.
3
[ROC (receiver operating characteristics) curve: principles and application in biology].
Hélène Delacour, A Servonnet, Andreas Perrot et al. · PubMed · 2005 · 74 citations
[Assessment of comorbidity in elderly].
Óscar Rosas‐Carrasco, Eduardo González-Flores, Ana M Brito-Carrera et al. · PubMed · 2011 · 29 citations